• When faster is not better: New study links premature development of human neurons to brain developmental disorders

    Thursday August 8th 2024

  • Rejuvenate Biomed and SAS tap AI to develop disease-agnostic drug repurposing discovery tools

    Thursday August 1st 2024

  • ACROBiosystems Launches GMP Brand Resilient Supply at ISSCR to Accelerate Cell and Gene Therapy Development

    Thursday August 1st 2024

  • Confo Therapeutics Announces EUR 60M Series B Financing to Advance Pipeline of Novel GPCR-Modulating Therapies into Clinical Development

    Friday July 26th 2024

  • Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch

    Tuesday July 23rd 2024

  • Antonin (Tony) de Fougerolles appointed as new Chair of etherna

    Tuesday July 16th 2024

  • ONTOFORCE Achieves ISO 27001:2022 Certification: A Milestone in Information Security and Trust

    Tuesday July 16th 2024

  • Ghent University spin-off Trince wins Nature Spinoff Prize

    Monday July 15th 2024

  • Your news here?

  • Agomab Bolsters Executive Team with Appointment of Pierre Kemula as Chief Financial Officer

    Friday July 12th 2024

  • Agomab Appoints Industry Veteran David Epstein as Chairman of its Board of Directors

    Wednesday July 10th 2024

  • Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors

    Monday July 8th 2024


Strategic Partners